product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Human anti Human ADAP
catalog :
HCA092
quantity :
0.1 mg
price :
264 USD
clonality :
monoclonal
host :
human
conjugate :
nonconjugated
clone name :
AbD06348
reactivity :
human
application :
ELISA, immunoprecipitation
more info or order :
image
image 1 :
ADAP (shown in red) and it's direct interaction partner SKAP55 (shown in green) immunoprecipitated from Jurkat lysate using Human anti ADAP clone AbD06348 (HCA092). An irrelevant IgG was used as IP control and Jurkat lysate as Western blot control. This image was kindly provided by R. Lehmann, Leibniz-Institute for Molecular Pharmacology, Berlin, Germany
product information
Entity Type :
Monoclonal Antibody
Entity Category :
Antibodies
ProductCode :
HCA092
Description :
Human anti Human ADAP
Specificity :
ADAP
TargetSpecies :
Human
Host :
Human
Format :
Purified
Isotypes :
HuCAL Fab bivalent
Applications :
E,IP
ApplicationTypes :
ELISA,Immunoprecipitation
Clone :
AbD06348
Quantity :
0.1 mg
Quantity Value :
0.1
Quantity Type :
mg
GO Accessions :
GO:0005515,GO:0005829,GO:0005634,GO:0006468,GO:0006607,GO:0006955,GO:0007243,GO:0034329,GO:0050852
GOTerms :
protein binding,cytosol,nucleus,protein phosphorylation,NLS-bearing substrate import into nucleus,immune response,intracellular protein kinase cascade,cell junction assembly,T cell receptor signaling pathway
Uniprot Accessions :
O15117
Gene :
FYB
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=2533
Entity Formats :
Purified
UNSPSC :
41116161
Concentration :
0.5 mg/ml
Product Form :
A bivalent human recombinant Fab selected from the HuCAL phage display library, expressed in E. coli. The antibody is tagged with a myc-tag (EQKLISEEDL) and a his-tag (HHHHHH) at the C-terminus of the antibody heavy chain. This Fab fragment is dimerized via a helix-turn-helix motif. This antibody is supplied liquid.
PriceGBP :
189
PriceEUR :
264
PriceUSD :
264 USD
PriceCHF :
287
PriceSEK :
2878
PriceNOK :
2892
PriceDKK :
1968
more info or order :
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.